Trials / Unknown
UnknownNCT03176342
Drug Patch Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)
Drug Patch Tests, Enzyme-linked Immunosorbent Spot Assay (Elispot) and Lymphocyte Transformation Tests in Patients With Severe Cutaneous Adverse Reaction to Drugs (SCARs)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Chulalongkorn University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The study is about drug patch tests in patients who have history of severe cutaneous drug reaction including Steven Johnson syndrome (SJS), toxic epidermal necrolysis (TEN), Drug-induced eosinophilia and systemic symptoms (DRESS), AGEP (Acute generalized exanthematous pustulosis) and generalized bullous fixed drug eruptions. This study also investigate in Enzyme-linked immunosorbent spot assay (ELIspot) and lymphocyte transformation test. We also trying to prove the correlation among result of drug patch tests, ELIspot and LTT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | patch test | Patch test allergen from chemotechnique diagnostics, pure drug and drug as is combine with petrolatum or aqueous. |
Timeline
- Start date
- 2016-08-04
- Primary completion
- 2017-08-03
- Completion
- 2017-08-03
- First posted
- 2017-06-05
- Last updated
- 2017-06-06
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT03176342. Inclusion in this directory is not an endorsement.